Bulios Research Team Bulios Black This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription. @research 1M Read More Avtomatizacija z umetno inteligenco raste in to podcenjeno podjetje poroča o preobratu v denarnem toku 30. 9. 2025 Read More
Bulios Research Team Bulios Black This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription. @research 1M Read More ExxonMobil | Q2 2025: rast proizvodnje in milijarde za vlagatelje 30. 9. 2025 Read More
Bulios Research Team Bulios Black This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription. @research 1M Read More Zakaj analitiki Microsoft označujejo za najboljšo delnico v tem trenutku? 29. 9. 2025 Read More
Bulios Research Team Bulios Black This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription. @research 1M Read More Chevron | 2. četrtletje 2025: slabši dobiček, rekordna proizvodnja in krepitev portfelja 29. 9. 2025 Read More
Bulios Research Team Bulios Black This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription. @research 1M Read More Amazon | 2. četrtletje 2025: dvomestna rast prihodkov, močan sistem AWS in največji dan Prime 26. 9. 2025 Read More
Bulios Research Team Bulios Black This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription. @research 1M Read More Podjetje gradi največjo mrežo centrov za duševno zdravje v ZDA, njegovo poslovanje pa hitro raste. 25. 9. 2025 Read More
Bulios Research Team Bulios Black This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription. @research 1M Read More Apple | 3. četrtletje 2025: rekordno četrtletje rasti za telefone iPhone, računalnike Mac in storitve 25. 9. 2025 Read More
Bulios Research Team Bulios Black This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription. @research 1M Read More Bristol Myers Squibb | 2. četrtletje 2025: močna rast portfelja kljub enkratnim stroškom 24. 9. 2025 Read More
Bulios Research Team Bulios Black This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription. @research 1M Read More Skrito gonilo razcveta polprevodnikov: podjetje, ki preizkuša prihodnost 23. 9. 2025 Read More
Bulios Research Team Bulios Black This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription. @research 1M Read More Shell | 2. četrtletje 2025: močan denarni tok in nadaljnji odkupi 23. 9. 2025 Read More
Bulios Research Team Bulios Black This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription. @research 1M Read More CVS Health | 2. četrtletje 2025: rast prihodkov, višje napovedi dobička 22. 9. 2025 Read More
Bulios Research Team Bulios Black This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription. @research 1M Read More Revolucija v kvantnem računalništvu? Podjetje z edinstveno tehnologijo in tveganim vrednotenjem 19. 9. 2025 Read More
Bulios Research Team Bulios Black This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription. @research 1M Read More British American Tobacco | 2. četrtletje 2025: ponovna rast v ZDA in potrjeni obeti za preostanek leta 19. 9. 2025 Read More
Bulios Research Team Bulios Black This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription. @research 1M Read More Nov igralec na področju jedrske energije: delnice so zrasle zaradi prebojne mikroreaktorske tehnologije 18. 9. 2025 Read More
Bulios Research Team Bulios Black This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription. @research 1M Read More AbbVie | 2. četrtletje 2025: ključna zdravila spodbujajo rast, vodstvo izboljšuje napovedi 18. 9. 2025 Read More
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
Avtomatizacija z umetno inteligenco raste in to podcenjeno podjetje poroča o preobratu v denarnem toku
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
ExxonMobil | Q2 2025: rast proizvodnje in milijarde za vlagatelje
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
Zakaj analitiki Microsoft označujejo za najboljšo delnico v tem trenutku?
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
Chevron | 2. četrtletje 2025: slabši dobiček, rekordna proizvodnja in krepitev portfelja
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
Amazon | 2. četrtletje 2025: dvomestna rast prihodkov, močan sistem AWS in največji dan Prime
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
Podjetje gradi največjo mrežo centrov za duševno zdravje v ZDA, njegovo poslovanje pa hitro raste.
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
Apple | 3. četrtletje 2025: rekordno četrtletje rasti za telefone iPhone, računalnike Mac in storitve
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
Bristol Myers Squibb | 2. četrtletje 2025: močna rast portfelja kljub enkratnim stroškom
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
Skrito gonilo razcveta polprevodnikov: podjetje, ki preizkuša prihodnost
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
Shell | 2. četrtletje 2025: močan denarni tok in nadaljnji odkupi
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
CVS Health | 2. četrtletje 2025: rast prihodkov, višje napovedi dobička
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
Revolucija v kvantnem računalništvu? Podjetje z edinstveno tehnologijo in tveganim vrednotenjem
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
British American Tobacco | 2. četrtletje 2025: ponovna rast v ZDA in potrjeni obeti za preostanek leta
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
Nov igralec na področju jedrske energije: delnice so zrasle zaradi prebojne mikroreaktorske tehnologije
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
AbbVie | 2. četrtletje 2025: ključna zdravila spodbujajo rast, vodstvo izboljšuje napovedi